Locally recurrent, previously irradiated head and neck cancer: Concurrent re-irradiation and chemotherapy, or chemotherapy alone?

Journal of Clinical Oncology

Volumn 24, Issue 17, 2006, Pages 2653-2658

  Wong, Stuart J ^a   Machtay, Mitchell ^a   Li, Yi ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ERLOTINIB; FLUOROURACIL; METHOTREXATE; PACLITAXEL; ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER SURVIVAL; HEAD AND NECK CANCER; HUMAN; INTERMETHOD COMPARISON; IRRADIATION; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEAD AND NECK TUMOR; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SALVAGE THERAPY; SECOND CANCER; SQUAMOUS CELL CARCINOMA; SURVIVAL; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PACLITAXEL; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 33748177338     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.3850     Document Type: Review

References (43)

1. Kotwall C, Sako K, Razack MS, et al: Metastatic patterns in squamous cell cancer of the head and neck. Am J Surg 154:439-442, 1987
2. Nishijima W, Takooda S, Tokita N, et al: Analyses of distant metastases in squamous cell carcinoma of the head and neck and lesions above the clavicle at autopsy. Arch Otolaryngol Head Neck Surg 119:65-68, 1993
3. Argiris A, Li Y, Forastiere A: Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck. Cancer 101:2222-2229, 2004
4. Forastiere A, Koch W, Trotti A, et al: Head and neck cancer. N Engl J Med 345:1890-1900, 2001
5. Pernot M, Malissard L, Hoffstetter S, et al: The study of tumoral, radiobiological, and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation. Int J Radiat Oncol Biol Phys 29:673-679, 1994
6. Calais G, Bardet E, Sire C, et al: Radiotherapy with concomitant weekly docetaxel for stages III/IV oropharynx carcinoma: Results of the 98-02 GORTEC phase II trial. Int J Radiat Oncol Biol Phys 58:161-166, 2004
7. Jeremic B, Shibamoto Y, Milicic B, et al: Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial. J Clin Oncol 18:1458-1464, 2000
8. Lefebvre JL, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial - EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890-899, 1996
9. Forastiere AA, Goepfert H, Maor M, et al: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091-2098, 2003
10. Cooper JS, Pajak TF, Forastiere AA, et al: Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937-1944, 2004
11. Bernier J, Domenge C, Ozsahin M, et al: Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945-1952, 2004
12. Bernier J, Cooper JS, Pajak TF, et al: Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 27:843-850, 2005
13. Leon X, Quer M, Diez S, et al: Second neoplasm in patients with head and neck cancer. Head Neck 21:204-210, 1999
14. Cooper JS, Pajak TF, Rubin P, et al: Second malignancies in patients who have head and neck cancer: Incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 17:449-456, 1989
15. Lippman SM, Hong WK: Second malignant tumors in head and neck squamous cell carcinoma: The overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 17:691-694, 1989
16. Khuri FR, Kim ES, Lee JJ, et al: The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev 10:823-829, 2001
17. Do KA, Johnson MM, Doherty DA, et al: Second primary tumors in patients with upper aerodigestive tract cancers: Joint effects of smoking and alcohol (United States). Cancer Causes Control 14: 131-138, 2003
18. Trotti A, Fu KK, Pajak TF, et al: Long term outcomes of RTOG 90-03: A comparison of hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 63, 2005 (suppl; abstr 116)
19. Taussky D, Dulguerov P, Allal AS: Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas. Head Neck 27:182-186, 2005
20. Temam S, Koka V, Mamelle G, et al: Treatment of the N0 neck during salvage surgery after radiotherapy of head and neck squamous cell carcinoma. Head Neck 27:653-658, 2005
21. Machtay M, Rosenthal DI, Chalian AA, et al: Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 59:72-77, 2004
22. Janot F, De Rancourt D, Castaing M, et al: Re-irradiation combined with chemotherapy after salvage surgery in head and neck carcinoma: A randomized trial from the GETTEC and GORTEC groups. J Clin Oncol 24:282s, 2006 (abstr 5508)
23. Salama JK, Vokes EE, Chmura SJ, et al: Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 64:382-391, 2005
24. Langlois D, Eschwege F, Kramar A, et al: Reirradiation of the head and neck cancers. Radiother Oncol 3:27-33, 1985
25. Emami B, Spector GJ, Bignardi M: Reirradiation of recurrent head and neck cancers. Laryngoscope 97:85-88, 1987
26. Wang CC, McIntyre J: Reirradiation of laryngeal carcinoma: Techniques and results. Int J Radiat Oncol Biol Phys 26:783-785, 1993
27. Stevens KR, Britsch A, Moss WT: High-dose reirradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys 29:687-698, 1994
28. Haraf DJ, Weichselbaum RR, Vokes EE: Reirradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: A potentially curable disease. Ann Oncol 7:913-918, 1996
29. De Crevoisier R, Bourhis J, Domenge C, et al: Full-dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol 16:3556-3562, 1998
30. Ohizumi Y, Tamai Y, Imamiya S, et al: Prognostic factors of reirradiation for recurrent head and neck cancer. Am J Clin Oncol 25:408-413, 2002
31. Spencer SA, Harris J, Wheeler RH, et al: RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 51:1299-1304, 2001
32. Horwitz EM, Harris J, Langer CJ, et al: Concurrent split course hyperfractionated radiotherapy (Hfx RT), cisplatin (DDP) and paclitaxel (P) in patients with recurrent, previously irradiated squamous cell carcinoma of the head and neck (SCCHN): Update of RTOG 9911. J Clin Oncol 23:519s, 2005 (suppl; abstr 5577)
33. Forastiere AA, Metch B, Schuller DE, et al: Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study. J Clin Oncol 10:1245-1251, 1992
34. Forastiere AA, Leong T, Rowinsky E, et al: Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393. J Clin Oncol 19:1088-1095, 2001
35. Gibson MK, Li Y, Murphy B, et al: Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): An intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol 23:3562-3567, 2005
36. Soulieres D, Senzer NN, Vokes EE, et al: Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck. J Clin Oncol 22:77-85, 2004
37. Hehr T, Classen J, Belka C, et al: Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: A prospective phase I/II trial. Int J Radiat Oncol Biol Phys 61:1423-1431, 2005
38. Denis F, Garaud P, Bardet E, et al: Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced stage oropharynx carcinoma: Comparison of the LENT/SOMA, RTOG/ EORTC, and the NCI-CTC scoring sytems. Int J Radiat Oncol Biol Phys 55:93-98, 2003
39. Murros KE, Toole JF: The effect of radiation on carotid arteries: A review article. Arch Neurol 46:449-455, 1989
40. Atkinson JL, Sundt TM Jr, Dale AJ, et al: Radiation-associated atheromatous disease of the cervical carotid artery: Report of seven cases and review of the literature. Neurosurgery 24:171-178, 1989
41. Martin JD, Buckley AR, Graeb D, et al: Carotid artery stenosis in asymptomatic patients who have received unilateral head-and-neck irradiation. Int J Radiat Oncol Biol Phys 63:1197-1205, 2005
42. Dorresteijn LD, Kappelle AC, Scholz NM, et al: Increased carotid wall thickening after radiotherapy on the neck. Eur J Cancer 41:1026-1030, 2005 May.
43. Dorresteijn LD, Kappelle AC, Boogerd W, et al: Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol 20:282-288, 2002